Cargando…
Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Achieve Similar Early Improvements in Beta-cell Function in Obese Patients with Type 2 Diabetes
Bariatric surgery is a treatment option for obese patients with type 2 diabetes mellitus (T2DM). Although sleeve gastrectomy (SG) is growing in favor, some randomized trials show less weight loss and HbA1c improvement compared with Roux-en-Y gastric bypass (RYGB). The study objective was to compare...
Autores principales: | Mullally, Jamie A., Febres, Gerardo J., Bessler, Marc, Korner, Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372630/ https://www.ncbi.nlm.nih.gov/pubmed/30755673 http://dx.doi.org/10.1038/s41598-018-38283-y |
Ejemplares similares
-
Prospective study of gut hormone and metabolic changes after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass
por: Arakawa, Rachel, et al.
Publicado: (2020) -
Roux-en-Y Gastric Bypass Is Associated With Hyperinsulinemia But Not Increased Maximal β-Cell Function
por: Georgia, Annette, et al.
Publicado: (2019) -
Prospective Study of Gut Hormone and Metabolic Changes After Adjustable Gastric Banding and Roux-en-Y Gastric Bypass
por: Korner, Judith, et al.
Publicado: (2009) -
Outcome of Sleeve Gastrectomy Converted to Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass
por: Felsenreich, D. M., et al.
Publicado: (2022) -
No Differences in Metabolic Parameters Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy, Regardless of Achieved Weight Loss
por: Holanda, Narriane Chaves Pereira, et al.
Publicado: (2021)